Loading company
TAKTakeda Pharmaceutical Company Limited$33.5BAShares of revenue are estimates for year ended March 31, 2026, not figures from a filing.
Regular traditional Chinese medicine pieces
Medicinal plants processed into forms such as cut pieces or powders, generally prepared by boiling or decoction before use.
Directly-Oral advanced TCMP
Processed herbal medicines made to be taken by mouth without first being boiled as a decoction.
After-Soaking-Oral advanced TCMP
Small sealed bags of herbal material steeped in hot water to make an infusion.
SanQiFen
A directly swallowed powder made from the roots and rhizomes of notoginseng.
CuYanHuSuo
A directly swallowed powder made from the tubers of Corydalis yanhusuo.
LuXueJing
A directly swallowed product made from dried deer blood.
China SXT makes traditional Chinese medicine pieces (TCMP) from medicinal plants, including herbs prepared as powders and other forms. In the fiscal year ended March 31, 2026, regular TCMP made up 95.02% of revenue (FY2026, high), while advanced TCMP made up 4.35% (FY2026, high); some advanced products can be swallowed directly or steeped in hot water. Total revenue was $1,138,052 (year ended March 31, 2026, high).
Built from China SXT Pharmaceuticals, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
The themes China SXT Pharmaceuticals is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
SXTC · Nasdaq · Healthcare · Drug Manufacturers Specialty and Generic
$2.89-3.7%Nov 11 close
Figures through March 31, 2026, from the 20-F filed July 1, 2026
China SXT sells Chinese herbal medicines, mainly traditional Chinese medicine pieces, to hospitals and pharmaceutical distributors in China.
Grade F-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 15 quarters of China SXT Pharmaceuticals, Inc.’s grade history. The other 13 go back to August 2019.
